# Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study

> **NCT02469272** · PHASE1 · UNKNOWN · sponsor: **Lifespan** · enrollment: 5 (estimated)

## Conditions studied

- Nonalcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Fecal Microbiota Transplantation

## Key facts

- **NCT ID:** NCT02469272
- **Lead sponsor:** Lifespan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02469272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02469272, "Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02469272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*